Antiparasitic Drugs Market, By Product Type (Anthelmintics (Anticestodal Drugs, Antitrematodal Drugs, and Antinematodal Drugs) Antiprotozoal Agents (Antimalarials Agents Antibabesial Agents, Antiamoebic Agents, and Others (Trypanocidal Agents, Antileishma
Description
Antiparasitic drugs are utilized to address various types of infections caused by a wide array of parasites. Parasites are small organisms that reside on or inside humans and animals. There are numerous antiparasitic drugs available, each designed to target a specific parasite. Parasitic infections can arise from a multitude of parasites, with the three main types being ectoparasites, helminthes, and protozoa. Antiparasitic drugs play a crucial role in treating these infections. For example, anticestodal drugs are effective against tapeworms, antitrematodal drugs target flukes, antinematodal drugs are designed to combat roundworms, and antimalarial agents are employed in the treatment of malaria. Additionally, there are specific antiparasitic drugs such as antibabesial agents for Babesiosis, antiamoebic agents for amoebic infections, trypanocidal agents for trypanosomiasis, antileishmanial agents for leishmaniasis, antiscabietic agents for scabies, and pediculicides for lice infestations. These different classes of antiparasitic drugs help address the varied range of parasitic infections and play a vital role in the overall management and treatment of these conditions.
Market Dynamics
Initiatives and campaigns by governments, non-profit organizations, and market players like Novartis are underway to promote the widespread use of antiparasitic drugs and enhance the treatment of tropical diseases, including parasitic illnesses such as malaria, leishmaniasis, and Chagas disease. These efforts aim to increase the demand for antiparasitic drugs and consequently drive the growth of the global antiparasitic drugs market in the foreseeable future. For instance, in October 2021, the U.S. President's Malaria Initiative (PMI) introduced a new five-year strategy called 'End Malaria Faster'. The primary objective of this strategy is to eliminate malaria within a generation, aligning with global targets of saving over 4 million lives and preventing 1 billion cases by 2025. The five-year PMI strategy focuses on reducing health disparities, enhancing disease surveillance, and continuing to save lives. These proactive measures by various stakeholders, such as governments and organizations like Novartis, in combating parasitic diseases and promoting the use of antiparasitic drugs demonstrate a concerted effort to address the burden of these conditions and improve public health outcomes.
Key features of the study:
Market Dynamics
Initiatives and campaigns by governments, non-profit organizations, and market players like Novartis are underway to promote the widespread use of antiparasitic drugs and enhance the treatment of tropical diseases, including parasitic illnesses such as malaria, leishmaniasis, and Chagas disease. These efforts aim to increase the demand for antiparasitic drugs and consequently drive the growth of the global antiparasitic drugs market in the foreseeable future. For instance, in October 2021, the U.S. President's Malaria Initiative (PMI) introduced a new five-year strategy called 'End Malaria Faster'. The primary objective of this strategy is to eliminate malaria within a generation, aligning with global targets of saving over 4 million lives and preventing 1 billion cases by 2025. The five-year PMI strategy focuses on reducing health disparities, enhancing disease surveillance, and continuing to save lives. These proactive measures by various stakeholders, such as governments and organizations like Novartis, in combating parasitic diseases and promoting the use of antiparasitic drugs demonstrate a concerted effort to address the burden of these conditions and improve public health outcomes.
Key features of the study:
- This report provides in-depth analysis of the global antiparasitic drugs market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antiparasitic drugs market based on the following parameters– company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Merck KGaA, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd, Cipla Limited, Cadila Pharmaceuticals, Watson International Limited, Vivaldis, Glenmark Pharmaceuticals Limited, Viatris Inc., Novartis AG, AdvaCare Pharma, Lupin, Sun Pharmaceutical Industries Ltd., and Aurobindo Pharma
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global antiparasitic drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antiparasitic drugs market
- Global Antiparasitic Drugs Market, By Product Type:
- Anthelmintics
- Anticestodal Drugs
- Antitrematodal Drugs
- Antinematodal Drugs
- Antiprotozoal Agents
- Antimalarials Agents
- Antibabesial Agents
- Antiamoebic Agents
- Others (Trypanocidal Agents, Antileishmanial Agents, etc.)
- Ectoparasiticide
- Antiscabietic Agents
- Pediculicides
- Global Antiparasitic Drugs Market, By Route of Administration:
- Oral
- Injectable
- Topical
- Global Antiparasitic Drugs Market, By Application:
- Human Health
- Animal Health
- Crop Health
- Global Antiparasitic Drugs Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Merck KGaA.
- GlaxoSmithKline plc.
- Reddy’s Laboratories Ltd
- Cipla Limited
- Cadila Pharmaceuticals
- Watson International Limited
- Vivaldis
- Viatris Inc.
- Novartis AG
- AdvaCare Pharma
- Lupin
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Glenmark Pharmaceuticals Limited
Table of Contents
212 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Route Of Administration
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Merger, Acquisition, Collaborations
- Funding and Investment
- Future Prospective of Antiparasitic Drugs
- Regulatory Guideline and Compliances
- Key Developments
- PEST Analysis
- PORTER’s Analysis
- 4. Global Antiparasitic Drugs Market– COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Antiparasitic Drugs Market, By Product Type, 2020–2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 – 2032
- Segment Trends
- Anthelmintics
- Anticestodal Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Antitrematodal Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Antinematodal Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Antiprotozoal Agents
- Antimalarials Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Antibabesial Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Antiamoebic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Others (Trypanocidal Agents, Antileishmanial Agents, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Ectoparasiticide
- Antiscabietic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Pediculicides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- 6. Global Antiparasitic Drugs Market, By Route of Administration, 2020 -2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 – 2032
- Segments Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- 7. Global Antiparasitic Drugs Market, By Application, 2020 – 2032, (US$ Billion)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 – 2032
- Segments Trends
- Human Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Animal Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- Crop Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Billion)
- 8. Global Antiparasitic Drugs Market, By Region, 2020 – 2032, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021–2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 – 2032, (US$ Billion)
- North Africa
- Central Africa
- South Africa
- 9. Competitive Landscape
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GlaxoSmithKline plc
- Cipla Limited
- Cadila Pharmaceuticals
- Watson International Limited
- Vivaldis
- Glenmark Pharmaceuticals Limited
- Advanced Bioscience Laboratories, Inc.
- Viatris Inc.
- Novartis AG
- AdvaCare Pharma
- Lupin
- Catalent, Inc
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- 10. Section
- Research Methodology
- About Us
- *Browse 32 market data tables and 36 figures on “Global Antiparasitic Drugs Market”- Global forecast to 2032
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
